scispace - formally typeset
D

Denise M. Boudreau

Researcher at University of Washington

Publications -  109
Citations -  7065

Denise M. Boudreau is an academic researcher from University of Washington. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 43, co-authored 104 publications receiving 6292 citations. Previous affiliations of Denise M. Boudreau include Group Health Research Institute & Group Health Cooperative.

Papers
More filters
Journal ArticleDOI

De facto long-term opioid therapy for noncancer pain.

TL;DR: The proposed threshold for long-term opioid therapy provides a checkpoint for physicians to review whether an explicit decision to sustain opioid therapy has been reached, and to ensure that a documented treatment plan and provisions for monitoring medication use and patient outcomes are in place.
Journal ArticleDOI

Trends in long-term opioid therapy for chronic non-cancer pain.

TL;DR: To report trends and characteristics of long‐term opioid use for non‐cancer pain for non-cancer pain, a large number of patients with a history of abuse or dependence are surveyed for the first time.
Journal ArticleDOI

Use of antidepressant medications during pregnancy: a multisite study

TL;DR: The finding that nearly 8% of pregnant women were prescribed antidepressants drugs during the years 2004 and 2005 highlights the importance of understanding the effects of these medications on the developing fetus and on the pregnant woman.
Journal ArticleDOI

Age and Gender Trends in Long-Term Opioid Analgesic Use for Noncancer Pain

TL;DR: Age and gender trends in long-term use of prescribed opioids for chronic noncancer pain in 2 large health plans show women had higher opioid use than did men and Concurrent use of sedative-hypnotic drugs and opioids was common, particularly among women.
Journal ArticleDOI

Statin use and cancer risk: a comprehensive review.

TL;DR: Evidence on the association between statin use and cancer risk is reviewed, with the exception of consistent evidence that statins are associated with reduced risk of advanced/aggressive prostate cancer.